Moreover, we examined potentially differential effects of desvenlafaxine based on psychiatric conditions (e.g., depression and insomnia) and inflammatory processes, as indicated by elevated levels of pro-inflammatory cytokines (e.g., interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α). This evidence concerns the gene IL6 and major depressive disorder.